BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30143404)

  • 1. Inter-observer reproducibility of the Royal College system for reporting thyroid cytology: Experience of the Egyptian National Cancer Institute.
    Ezzat NE; Abusinna ES; Hafez NH; Alieldin NH
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):85-91. PubMed ID: 30143404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system.
    Kocjan G; Chandra A; Cross PA; Giles T; Johnson SJ; Stephenson TJ; Roughton M; Poller DN
    Am J Clin Pathol; 2011 Jun; 135(6):852-9. PubMed ID: 21571958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid cytology-histology correlation using the RCPath terminology for thyroid cytology reporting.
    Parkinson D; Aziz S; Bentley R; Johnson SJ
    J Clin Pathol; 2017 Aug; 70(8):648-655. PubMed ID: 28082414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving our departmental reporting of thyroid cytology specimens against national guidelines: A two-cycle retrospective audit.
    Halliday E; Harrison E; Sansom H; Ahsan SF; Harrison K
    Cytopathology; 2020 Nov; 31(6):514-524. PubMed ID: 32301536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules.
    Lobo C; McQueen A; Beale T; Kocjan G
    Acta Cytol; 2011; 55(6):499-506. PubMed ID: 22156457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features and diagnostic accuracy of fine needle aspiration cytology of thyroid nodules: retrospective study from Oman.
    Alhassan R; Al Busaidi N; Al Rawahi AH; Al Musalhi H; Al Muqbali A; Shanmugam P; Ramadhan FA
    Ann Saudi Med; 2022; 42(4):246-251. PubMed ID: 35933603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignancy in the various categories of the UK Royal College of Pathologists Thy terminology for thyroid FNA cytology: A systematic review and meta-analysis.
    Poller DN; Bongiovanni M; Trimboli P
    Cancer Cytopathol; 2020 Jan; 128(1):36-42. PubMed ID: 31722134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid diagnostic modalities (fine needle aspiration and core needle biopsy) with histology correlation: a tertiary centre experience.
    Appukutty SJ; Paterson A; Patel NS; Duckworth A; Chan J; O'Donovan M; Marker AJ
    J Clin Pathol; 2022 Sep; 75(9):620-626. PubMed ID: 34531287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is Thy3a? A study of 336 Thy3a (AUS/FLUS) thyroid FNAs with histology compares UK RCPath with other reporting systems and shows how Thy3a subclassification can improve risk stratification and help address overuse of this category.
    van der Horst C; Wright S; Young D; Tailor H; Clark L
    Cytopathology; 2021 Jan; 32(1):29-36. PubMed ID: 32892464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Inter-observer Agreement Among the Members of the Italian Consensus for the Classification and Reporting of Thyroid Cytology.
    Crescenzi A; Trimboli P; Basolo F; Frasoldati A; Orlandi F; Palombini L; Papini E; Pontecorvi A; Vitti P; Zini M; Nardi F; Fadda G
    Endocr Pathol; 2020 Sep; 31(3):301-306. PubMed ID: 32621106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
    Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
    Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular nodules (THY3) of the thyroid: we recommend surgery.
    Gheri RG; Romoli E; Vezzosi V; Ragghianti B; Bianchi S; Pedercini S; Dainelli F; Panconesi R
    J Endocrinol Invest; 2011; 34(7):e183-7. PubMed ID: 21169729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thy 3F and 3a malignancy rate, a multisite regional retrospective case series.
    Alexander V; Rudd J; Walker D; Wong G; Lunt A; Hamakarim Z; Bell S; Balfour A; Davis J; Pitkin L; Pelser A
    Ann R Coll Surg Engl; 2018 Sep; 100(7):545-550. PubMed ID: 29968505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Thy 1-non-diagnostic thyroid fine needle aspiration using the UK Royal College of Pathologists Thy Terminology. A systematic review of the literature comparing patients who undergo rapid on-site evaluation and those who do not.
    Poller DN; Doyle V; Trimboli P; Bongiovanni M
    Cytopathology; 2020 Nov; 31(6):502-508. PubMed ID: 32003044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypia of Undetermined Significance in Thyroid Fine Needle Aspirates: a 4-Year Audit of Thy3a Reporting.
    Mullen D; Mullins S; Doyle A; Crowley RK; Skehan S; McDermott EW; Prichard RS; Gibbons D
    Eur Thyroid J; 2017 Sep; 6(5):271-275. PubMed ID: 29071240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
    Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
    Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and diagnostic reproducibility of the thyroid cytology "indeterminate categories" SIAPEC/SIE 2014 in a consecutive series of 302 cases.
    Massa F; Caraci P; Sapino A; De Rosa G; Volante M; Papotti M
    J Endocrinol Invest; 2021 Apr; 44(4):803-809. PubMed ID: 32797379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
    Tepeoğlu M; Bilezikçi B; Bayraktar SG
    Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.